This post is hidden. Please check "Display" below to show it on your blog page.
Jun 22nd 2009, 03:45 PM
0 raters
Paxil Weight Loss
Early results of new studies show that Paxil Weight Loss
increases the risk of birth defects, particularly heart defects, when women take it during the first three months of pregnancy. Paxil Weight Loss
should usually not be taken during pregnancy, but for some
women who have already been taking Paxil Weight Loss
, the benefits of continuing Paxil Weight Loss
may be greater than the potential risk to the baby. Women taking Paxil Weight Loss
who are pregnant, think they may be pregnant, or plan to become pregnant should talk to their
physicians about the potential risks of taking Paxil Weight Loss
during pregnancy. The early results of two studies showed that women who took Paxil Weight Loss
(Paxil Weight Loss
) during the first three months of pregnancy were about one and a half to two times as likely to
have a baby with a heart defect as women who received other antidepressants, and women in the general population. Most of the heart defects in these studies were not life- threatening, and happened mainly in the inside walls of the heart muscle where repairs
can be done if needed (atrial and ventricular septal defects). Sometimes these septal defects resolve without treatment. In one of the studies, the risk of heart defects in babies whose mothers had taken Paxil Weight Loss
early in pregnancy was 2%, compared to a 1% risk
in the whole population. In the other study, the risk of heart defects in babies whose mothers had taken Paxil Weight Loss
in the first three months of pregnancy was 1.5%, compared to 1% in babies whose mothers had taken other antidepressants in the first three months
of pregnancy. This study also showed that women who took Paxil Weight Loss
in the first three months of pregnancy were about twice as likely to have a baby with any birth defect as women who took other antidepressants.
A life-threatening condition called serotonin syndrome can happen when medicines called selective serotonin reuptake inhibitors (SSRIs), such as Paxil Weight Loss
and medicines used
to treat migraine headaches known “triptans” (e.g. sumatriptan/ Imitrex®) are used together. Signs and symptoms of serotonin syndrome may include: restlessness, hallucinations, loss of coordination, fast heart beat, increased body temperature, fast
changes in blood pressure, overactive reflexes, diarrhea, nausea, vomiting and coma. Serotonin syndrome may be more likely to occur when starting or increasing the dose of an SSRI or a triptan. Before you take Paxil Weight Loss
and a triptan together, talk to your healthcare professional. If you must take these medicines together, be aware of the possibility of serotonin syndrome, and get medical care right away if you think serotonin syndrome is happening to you.
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use
of Paxil Weight Loss
or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening,suicidality, or unusual changes in behavior. Families and caregivers should be advised of
the need for close observation and communication with the prescriber. Paxil Weight Loss
is not approved for use in pediatric patients What is Paxil Weight Loss
® and what does it treat? aroxetine is an antidepressant medication that works in the brain. It is approved for the treatment of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), social anxiety disorder (social phobia), panic disorder, Obsessive Compulsive Disorder
(OCD), Posttraumatic Stress Disorder (PTSD), and Premenstrual Dysphoric Disorder (PMDD). MDD occurs when a person experiences several of the following symptoms concurrently, for at least two weeks: "low" or depressed mood (for example, sad, empty, tearful); decreased interest in most or all activities; changes in appetite (usually decreased);
changes in sleep (usually poor sleep); loss of energy; feeling worthless/guilty/ hopeless/ helpless; psychomotor agitation or retardation (i.e. thoughts/movements speeding up or slowing down); difficulty concentrating, and thoughts of death (suicidal thinking).GAD occurs when a person experiences excessive anxiety or worry for at least six
months along with restlessness, fatigue, difficulty concentrating, irritability, muscle tension or sleep disturbance. Social Anxiety Disorder is an anxiety disorder in which a person experiences extreme fear in situations where they have to meet new people. The person may have physical
symptoms in social situations (e.g. blushing, sweating, shaking, dry mouth, palpitations) and commonly tries to avoid them
This post is hidden. Please check "Display" below to show it on your blog page.
Permalink
Rate this post:
